Peng Xue Selected Research

Doxorubicin (Adriamycin)

1/2022	Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy.
2/2021	Reduction-Responsive Chemo-Capsule-Based Prodrug Nanogel for Synergistic Treatment of Tumor Chemotherapy.
3/2019	Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer.
1/2019	Phase-Change Material Packaged within Hollow Copper Sulfide Nanoparticles Carrying Doxorubicin and Chlorin e6 for Fluorescence-Guided Trimodal Therapy of Cancer.
1/2019	Co-delivery of chlorin e6 and doxorubicin using PEGylated hollow nanocapsules for 'all-in-one' tumor theranostics.
1/2019	PEGylated mesoporous Bi2S3 nanostars loaded with chlorin e6 and doxorubicin for fluorescence/CT imaging-guided multimodal therapy of cancer.
12/2018	Injectable and Natural Humic Acid/Agarose Hybrid Hydrogel for Localized Light-Driven Photothermal Ablation and Chemotherapy of Cancer.
11/2018	Acid-active supramolecular anticancer nanoparticles based on cyclodextrin polyrotaxanes damaging both mitochondria and nuclei of tumor cells.
1/2018	Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
2/2017	Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peng Xue Research Topics

Disease

116	Neoplasms (Cancer) 03/2024 - 02/2009
17	Inflammation (Inflammations) 02/2024 - 04/2011
14	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2014
9	Hypoxia (Hypoxemia) 12/2023 - 01/2012
9	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2011
8	Pain (Aches) 02/2022 - 04/2013
8	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2012
6	Osteoporosis 01/2023 - 12/2016
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 04/2014
5	Periodontitis 10/2023 - 05/2014
5	Infections 03/2023 - 01/2009
5	Hyperthermia 01/2022 - 01/2018
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2003
5	Insulin Resistance 01/2016 - 04/2011
4	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 08/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 10/2017 - 01/2015
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 08/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2021
3	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2012
3	Shock 01/2022 - 01/2020
3	Starvation 01/2022 - 01/2020
3	Oral Lichen Planus 01/2021 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 09/2019 - 01/2003
3	Skin Neoplasms (Skin Cancer) 01/2013 - 01/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2024 - 02/2024
2	Body Weight (Weight, Body) 02/2024 - 11/2023
2	Carcinoma (Carcinomatosis) 10/2023 - 03/2023
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 01/2023
2	Carcinogenesis 03/2023 - 01/2018
2	Thrombosis (Thrombus) 01/2023 - 04/2019
2	Necrosis 05/2022 - 10/2018
2	Atrophy 02/2022 - 01/2021
2	Muscular Atrophy (Muscle Atrophy) 02/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2003
18	ProdrugsIBA 01/2022 - 11/2016
15	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2008
12	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2015
11	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 01/2018
11	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 04/2011
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 10/2018
10	MicellesIBA 01/2020 - 09/2017
8	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
7	Oxygen (Dioxygen)IBA 01/2022 - 11/2019
6	LipidsIBA 02/2024 - 08/2012
6	Therapeutic UsesIBA 01/2021 - 01/2018
6	ferric ferrocyanide (Prussian blue)FDA Link 03/2019 - 01/2015
6	ArsenicIBA 02/2013 - 01/2011
5	HydrogelsIBA 10/2023 - 12/2018
5	DisulfidesIBA 02/2023 - 01/2016
5	Glutathione (Reduced Glutathione)IBA 01/2023 - 01/2016
5	AcidsIBA 10/2021 - 11/2017
5	phytochlorinIBA 01/2020 - 10/2018
5	Insulin (Novolin)FDA Link 01/2020 - 04/2011
4	polyethylene glycol polyethyleneimine nanogelIBA 01/2023 - 02/2021
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023 - 01/2018
4	MicroRNAs (MicroRNA)IBA 01/2022 - 02/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 04/2017
4	PolymersIBA 09/2021 - 09/2017
4	CamptothecinIBA 02/2021 - 11/2017
4	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 01/2019
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020 - 02/2017
4	AntigensIBA 04/2014 - 03/2013
3	RNA (Ribonucleic Acid)IBA 04/2024 - 05/2017
3	SaponinsIBA 02/2024 - 02/2019
3	Peptides (Polypeptides)IBA 01/2023 - 01/2015
3	AntioxidantsIBA 01/2023 - 08/2012
3	SolutionsIBA 01/2023 - 02/2015
3	Amino Acids FDA Link 03/2022 - 05/2014
3	Fibroins (Fibroin)IBA 01/2022 - 01/2019
3	Liraglutide FDA Link 10/2020 - 10/2019
3	Sulfides (Thioethers)IBA 06/2020 - 01/2019
3	CopperIBA 06/2020 - 01/2019
3	CyclodextrinsIBA 11/2019 - 08/2018
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 01/2017
3	IsotopesIBA 02/2017 - 05/2014
3	CarbohydratesIBA 04/2014 - 02/2014
3	Carcinoembryonic AntigenIBA 04/2014 - 02/2014
2	Levodopa (L Dopa)FDA LinkGeneric 04/2024 - 02/2024
2	Antimycin AIBA 04/2024 - 02/2024
2	CatalaseIBA 03/2024 - 12/2023
2	GinsenosidesIBA 02/2024 - 04/2017
2	Bevacizumab (Avastin)FDA Link 01/2024 - 04/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 10/2018
2	manganese oxide (hausmannite)IBA 11/2023 - 01/2019
2	Long Noncoding RNAIBA 03/2023 - 01/2021
2	Glucose OxidaseIBA 02/2023 - 01/2020
2	Mannose ReceptorIBA 01/2023 - 01/2022
2	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2020
2	Granzymes (Granzyme)IBA 01/2023 - 02/2009
2	InterferonsIBA 10/2022 - 12/2021
2	Biocompatible Materials (Biomaterials)IBA 10/2022 - 01/2020

Therapy/Procedure

74	Therapeutics 12/2023 - 01/2015
30	Drug Therapy (Chemotherapy) 01/2024 - 01/2012
13	Precision Medicine 01/2023 - 11/2017
13	Lasers (Laser) 01/2022 - 03/2012
10	Immunotherapy 10/2023 - 01/2020
10	Photochemotherapy (Photodynamic Therapy) 01/2021 - 10/2018
7	Photothermal Therapy 01/2022 - 01/2015
4	Induced Hyperthermia (Thermotherapy) 01/2022 - 01/2020
3	Aftercare (After-Treatment) 02/2022 - 04/2019